ozempic semaglutide wikipedia | C187H291N45O59 | CID 56843331 Ozempic, Wegovy might lower Alzheimer's

The primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, improving glycaemic control without causing hypoglycaemia when glucose levels are normal Suppressed glucagon secretion : These agents inhibit inappropriate glucagon release from pancreatic alpha cells, reducing hepatic glucose production Delayed gastric emptying : By slowing the rate at which food leaves the stomach, GLP-1 medications prolong satiety and reduce postprandial glucose excursions Central appetite regulation : GLP-1 receptors in the hypothalamus and brainstem mediate reduced appetite and food intake, leading to decreased caloric consumption Regarding visceral fat specifically, some imaging substudies suggest GLP-1 receptor agonists may reduce visceral adipose tissue alongside subcutaneous fat

Gallbladder disease Tirzepatide and other GLP-1 drugs delay gallbladder emptying

Abruptly stopping insulin can cause dangerous hyperglycemia

Diabetes Metab Res Rev 40(2):e3739

Clinical Impact: Clinical studies and patient observations have shown that GLP-1 agonists can lead to substantial weight loss in individuals with severe obesity, including those with genetic syndromes like BBS